title: One foundation's strategy to accelerate drug discovery through genomics.
abstract: The Multiple Myeloma Research Foundation (MMRF) has the principal goal of accelerating development of next-generation drugs for treating multiple myeloma. By making targeted investments in key research areas such as genomics and epigenetics, the MMRF is helping to elucidate the basic biology of multiple myeloma, to drive promising new treatments into clinical development, and ultimately to link the right treatment to the right patient.
authors.affiliation: Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium, Norwalk, CT 06851, USA.
authors.forename: Louise M
authors.initials: LM
authors.lastname: Perkins
authors.forename: Anne Quinn
authors.initials: AQ
authors.lastname: Young
authors.forename: Kathy
authors.initials: K
authors.lastname: Giusti
mesh_terms: D055808:Drug Discovery / Q000379:methods*; D005582:Foundations; D023281:Genomics / Q000379:methods*